Arató M, Erdós A, Kurcz M, Vermes I, Fekete M
Acta Psychiatr Scand. 1980 Mar;61(3):239-44. doi: 10.1111/j.1600-0447.1980.tb00873.x.
Electroconvulsive therapy (ECT) and simulated ECT (SECT)-induced prolactin response has been studied in 14 schizophrenic males. Cortisol, growth hormone, and thyroid stimulating hormone (TSH) changes have been measured simultaneously. The prolactin rise was significantly higher after ECT than after SECT. Cortisol increase after ECT did not exceed significantly the elevation after SECT. Changes in growth hormone and TSH concentrations were inconsistent and non-significant. On the basis of the results it may be assumed that ECT-induced prolactin response is a consequence of specific transmitter changes in the CNS and not a result of stress reaction or generalized neuronal discharge. ECT-induced prolactin response was negligible in two cases. Both patients were chronically hospitalized schizophrenics resistant to therapy. Whether the prolactin response or its absence is of predictive value with respect to prognosis or effect of ECT remains to be seen.
对14名男性精神分裂症患者进行了电休克治疗(ECT)和模拟电休克治疗(SECT)诱导的催乳素反应研究。同时测量了皮质醇、生长激素和促甲状腺激素(TSH)的变化。ECT后催乳素升高明显高于SECT后。ECT后皮质醇增加未显著超过SECT后的升高水平。生长激素和TSH浓度变化不一致且无显著性。根据结果可以推测,ECT诱导的催乳素反应是中枢神经系统中特定递质变化的结果,而非应激反应或全身性神经元放电的结果。有两例ECT诱导的催乳素反应可忽略不计。这两名患者均为长期住院且对治疗耐药的精神分裂症患者。催乳素反应或其缺失对于ECT的预后或效果是否具有预测价值仍有待观察。